BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Han SX, Zhu Q, Ma JL, Zhao J, Huang C, Jia X, Zhang D. Lowered HGK expression inhibits cell invasion and adhesion in hepatocellular carcinoma cell line HepG2. World J Gastroenterol 2010; 16(36): 4541-4548 [PMID: 20857524 DOI: 10.3748/wjg.v16.i36.4541]
URL: https://www.wjgnet.com/1948-5182/full/v16/i36/4541.htm
Number Citing Articles
1
Jungjae Lee, Seoyun Kim, Jihyeung Ju. Effects of White Sesame Seed Extract and β-Sitosterol on Growth, Migration, and Adhesion of H1299 Human Lung Cancer CellsJournal of the Korean Society of Food Science and Nutrition 2015; 44(9): 1279 doi: 10.3746/jkfn.2015.44.9.1279
2
Koc-Kan Ho, K. Mark Parnell, Yi Yuan, Yong Xu, Steven G. Kultgen, Steven Hamblin, Thomas F. Hendrickson, Bai Luo, Jason M. Foulks, Michael V. McCullar, Steven B. Kanner. Discovery of 4-phenyl-2-phenylaminopyridine based TNIK inhibitorsBioorganic & Medicinal Chemistry Letters 2013; 23(2): 569 doi: 10.1016/j.bmcl.2012.11.013
3
Zhenjie Bai, Qingmei Yao, Zhongyi Sun, Fang Xu, Jicheng Zhou. Prognostic Value of mRNA Expression of MAP4K Family in Acute Myeloid LeukemiaTechnology in Cancer Research & Treatment 2019; 18: 153303381987392 doi: 10.1177/1533033819873927
4
Audrey Gallud, Ophélie Vaillant, Ludovic T. Maillard, Dominique P. Arama, Joëlle Dubois, Marie Maynadier, Vincent Lisowski, Marcel Garcia, Jean Martinez, Nicolas Masurier. Imidazopyridine-fused [1,3]-diazepinones: Synthesis and antiproliferative activityEuropean Journal of Medicinal Chemistry 2014; 75: 382 doi: 10.1016/j.ejmech.2014.01.044
5
Joseph V. Virbasius, Michael P. Czech. Map4k4 Signaling Nodes in Metabolic and Cardiovascular DiseasesTrends in Endocrinology & Metabolism 2016; 27(7): 484 doi: 10.1016/j.tem.2016.04.006
6
Huai-Chia Chuang, Chih-Chi Chang, Chiao-Fang Teng, Chia-Hsin Hsueh, Li-Li Chiu, Pu-Ming Hsu, Ming-Ching Lee, Chung-Ping Hsu, Yi-Rong Chen, Yi-Chung Liu, Ping-Chiang Lyu, Tse-Hua Tan. MAP4K3/GLK Promotes Lung Cancer Metastasis by Phosphorylating and Activating IQGAP1Cancer Research 2019; 79(19): 4978 doi: 10.1158/0008-5472.CAN-19-1402
7
Pieter H. Bos, Emily R. Lowry, Jonathon Costa, Sebastian Thams, Alejandro Garcia-Diaz, Arie Zask, Hynek Wichterle, Brent R. Stockwell. Development of MAP4 Kinase Inhibitors as Motor Neuron-Protecting AgentsCell Chemical Biology 2019; 26(12): 1703 doi: 10.1016/j.chembiol.2019.10.005
8
Xuan Gao, Chenxi Gao, Guoxiang Liu, Jing Hu. MAP4K4: an emerging therapeutic target in cancerCell & Bioscience 2016; 6(1) doi: 10.1186/s13578-016-0121-7
9
Darya A. Haas, Kiran Bala, Guntram Büsche, Magdalena Weidner-Glunde, Susann Santag, Semra Kati, Silvia Gramolelli, Modester Damas, Oliver Dittrich-Breiholz, Michael Kracht, Jessica Rückert, Zoltan Varga, György Keri, Thomas F. Schulz, Blossom Damania. The Inflammatory Kinase MAP4K4 Promotes Reactivation of Kaposi's Sarcoma Herpesvirus and Enhances the Invasiveness of Infected Endothelial CellsPLoS Pathogens 2013; 9(11): e1003737 doi: 10.1371/journal.ppat.1003737
10
Sunil Kumar Singh, Ruchi Roy, Sandeep Kumar, Piush Srivastava, Saket Jha, Basabi Rana, Ajay Rana. Molecular Insights of MAP4K4 Signaling in Inflammatory and Malignant DiseasesCancers 2023; 15(8): 2272 doi: 10.3390/cancers15082272
11
Mei-Hua Qiu, Yi-Ming Qian, Xiang-Li Zhao, Shou-Mei Wang, Xiao-Jun Feng, Xin-Fang Chen, Shu-Hui Zhang. Expression and prognostic significance of MAP4K4 in lung adenocarcinomaPathology - Research and Practice 2012; 208(9): 541 doi: 10.1016/j.prp.2012.06.001
12
Huai-Chia Chuang, Xiaohong Wang, Tse-Hua Tan. Advances in Immunology 2016; 129: 277 doi: 10.1016/bs.ai.2015.09.006
13
O A Kent, K Fox-Talbot, M K Halushka. RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targetsOncogene 2013; 32(20): 2576 doi: 10.1038/onc.2012.266
14
Sumit Kumar Anand, Mara Caputo, Ying Xia, Emma Andersson, Emmelie Cansby, Sima Kumari, Marcus Henricsson, Rando Porosk, Katharina Susanne Keuenhof, Johanna Louise Höög, Syam Nair, Hanns-Ulrich Marschall, Matthias Blüher, Margit Mahlapuu. Inhibition of MAP4K4 signaling initiates metabolic reprogramming to protect hepatocytes from lipotoxic damageJournal of Lipid Research 2022; 63(7): 100238 doi: 10.1016/j.jlr.2022.100238